Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)
China · Delayed Price · Currency is CNY 25.30
-0.74 (-2.84%)
Sep 9, 2026, 4:00 PM EDT
SHA:603207 Revenue
Shanghai Xiao Fang Pharmaceutical had revenue of 136.24M CNY in the quarter ending June 30, 2026, a decrease of -3.18%. This brings the company's revenue in the last twelve months to 537.42M, up 11.36% year-over-year. In the year 2025, Shanghai Xiao Fang Pharmaceutical had annual revenue of 525.28M with 10.68% growth.
Revenue (ttm)
537.42M
Revenue Growth
+11.36%
P/S Ratio
7.56
Revenue / Employee
1.02M
Employees
529
Market Cap
4.07B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 525.28M | 50.70M | 10.68% |
| Dec 31, 2024 | 474.58M | 2.71M | 0.57% |
| Dec 31, 2023 | 471.87M | 14.98M | 3.28% |
| Dec 31, 2022 | 456.89M | 55.12M | 13.72% |
| Dec 31, 2021 | 401.77M | 40.54M | 11.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Bioengineering | 23.66B |
| Jinling Pharmaceutical Company | 3.18B |
| Jianmin Pharmaceutical Group | 3.18B |
| Jinhe Biotechnology CO., LTD. | 2.94B |
| Tianjin Lisheng Pharmaceutical | 1.30B |
| Shandong Wohua Pharmaceutical | 784.94M |
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD | 737.90M |
| Sinotherapeutics | 418.12M |